409 related articles for article (PubMed ID: 8636959)
1. Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant.
Sjöström JE; Larsson H
J Med Microbiol; 1996 Jun; 44(6):425-33. PubMed ID: 8636959
[TBL] [Abstract][Full Text] [Related]
2. Sucralfate affects the susceptibility of Helicobacter pylori to antimicrobial agents.
Slomiany BL; Piotrowski J; Majka J; Slomiany A
Scand J Gastroenterol Suppl; 1995; 210():82-4. PubMed ID: 8578215
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship of omeprazole and analogues as Helicobacter pylori urease inhibitors.
Kühler TC; Fryklund J; Bergman NA; Weilitz J; Lee A; Larsson H
J Med Chem; 1995 Dec; 38(25):4906-16. PubMed ID: 8523404
[TBL] [Abstract][Full Text] [Related]
4. Urea, fluorofamide, and omeprazole treatments alter helicobacter colonization in the mouse gastric mucosa.
Aristoteli LP; O'Rourke JL; Danon S; Larsson H; Mellgard B; Mitchell H; Lee A
Helicobacter; 2006 Oct; 11(5):460-8. PubMed ID: 16961809
[TBL] [Abstract][Full Text] [Related]
5. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
6. Growth-inhibiting, bactericidal, and urease inhibitory effects of Paeonia lactiflora root constituents and related compounds on antibiotic-susceptible and -resistant strains of Helicobacter pylori.
Ngan LT; Moon JK; Shibamoto T; Ahn YJ
J Agric Food Chem; 2012 Sep; 60(36):9062-73. PubMed ID: 22891951
[TBL] [Abstract][Full Text] [Related]
7. Bactericidal effect of ecabet sodium on clarithromycin- and metronidazole-resistant clinical isolates of Helicobacter pylori.
Shibata K; Kasuga O; Yasoshima A; Matsushita T; Kawakami Y
Jpn J Antibiot; 1997 Jun; 50(6):525-31. PubMed ID: 9258741
[TBL] [Abstract][Full Text] [Related]
8. Effects of anti-ulcer agents on antibiotic activity against Helicobacter pylori.
Sunairi M; Watanabe K; Suzuki T; Tanaka N; Kuwayama H; Nakajima M
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S121-4. PubMed ID: 7735928
[TBL] [Abstract][Full Text] [Related]
9. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R
J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519
[TBL] [Abstract][Full Text] [Related]
10. The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism.
McGowan CC; Cover TL; Blaser MJ
Gastroenterology; 1994 Nov; 107(5):1573-8. PubMed ID: 7926527
[TBL] [Abstract][Full Text] [Related]
11. Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori.
Cederbrant G; Kahlmeter G; Schalén C; Kamme C
J Antimicrob Chemother; 1994 Dec; 34(6):1025-9. PubMed ID: 7730216
[TBL] [Abstract][Full Text] [Related]
12. Omeprazole may exert both a bacteriostatic and a bacteriocidal effect on the growth of Helicobacter pylori (NCTC 11637) in vitro by inhibiting bacterial urease activity.
Mirshahi F; Fowler G; Patel A; Shaw G
J Clin Pathol; 1998 Mar; 51(3):220-4. PubMed ID: 9659264
[TBL] [Abstract][Full Text] [Related]
13. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
14. In-vitro susceptibility of Helicobacter pylori to ampicillin, clarithromycin, metronidazole and omeprazole.
Loo VG; Fallone CA; De Souza E; Lavallée J; Barkun AN
J Antimicrob Chemother; 1997 Dec; 40(6):881-3. PubMed ID: 9462442
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
16. Bactericidal activity of lansoprazole and omeprazole against Helicobacter pylori in vitro.
Vogt K; Hahn H
Arzneimittelforschung; 1998 Jun; 48(6):694-7. PubMed ID: 9689430
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori.
Dai G; Cheng N; Dong L; Muramatsu M; Xiao S; Wang MW; Zhu DX
Antimicrob Agents Chemother; 2005 Aug; 49(8):3468-73. PubMed ID: 16048962
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori urease suppresses bactericidal activity of peroxynitrite via carbon dioxide production.
Kuwahara H; Miyamoto Y; Akaike T; Kubota T; Sawa T; Okamoto S; Maeda H
Infect Immun; 2000 Aug; 68(8):4378-83. PubMed ID: 10899833
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori containing only cytoplasmic urease is susceptible to acid.
Krishnamurthy P; Parlow M; Zitzer JB; Vakil NB; Mobley HL; Levy M; Phadnis SH; Dunn BE
Infect Immun; 1998 Nov; 66(11):5060-6. PubMed ID: 9784504
[TBL] [Abstract][Full Text] [Related]
20. [Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors].
Díaz-Reganon J; Alarcón T; Domingo D; López-Brea M
Rev Esp Quimioter; 2006 Mar; 19(1):34-8. PubMed ID: 16688289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
